Clinical laboratory adverse events after vaccination with Na-GST-1/Alhydrogel (with or without GLA-AF) or the hepatitis B vaccine in US and Brazilian adults.

Data are number (%) of participants experiencing an event after any vaccination. Results for the different doses of Na-GST-1 and GLA-AF are combined. Participants with more than one occurrence of the same adverse event are recorded only once, at the maximum severity experienced.